Big pharma's revenue mix is tilting back to homegrown drugs — organic assets hit 53% of top-15 sales by 2025. However, some ...

The US FDA has authorized Abbott’s Libre Duo 10 Day, the first wearable product to continuously track glucose and ketone ...

Paradromics gained FDA approval to expand its BCI access from research laptops to personal devices during clinical trials.

Bausch + Lomb said its eye drop combining the active ingredients from Xiidra and Miebo will soon move into Phase III. The ...

Employers responding to a Business Group on Health survey indicated they are cutting coverage or tightening utilization ...

The US FDA approval marks the second indication for the FcRn inhibitor after its April 2025 approval for generalized ...

The UK government has pledged up to £2m in funding for nine “cutting-edge” animal-free drug testing projects, with eventual ...

Amidate (etomidate) and generics are facing a pre-review by an international drug control committee, which could lead to ...

Exclusive: Bayer Consumer Health has staked its claim to the GLP-1 companion space, mapping existing brands to user symptoms ...

A pioneer of first-in-class oral peptide drugs, Protagonist has opted to let big pharma partners bring its first two products ...

Neurotech company Axoft said it developed a new Fleuron material with the Shroff Lab for research use as it continues to ...

A signature from a New Jersey district court judge has finalized a battle over a settlement agreement that represented over a ...